6/17/2019WSJ: China Biotechs Lure Industry Talents in the U.S.

6/17/2019No. of Retail Pharmacies Hits Historical High as Retail Drug Sales Gro...

6/17/2019NHC Expects to Reduce Drug Price Further As 4+7 Trial Advances

6/14/2019Theravance and Mylan Expand YUPELRI (revefenacin) Deal to include Grea...

6/14/2019Sinovant Granted Chinese Clinical Trial Approval for Lefamulin

6/14/2019Chi-Med Announces Successful Surufatinib Phase III Study in China

6/14/2019BeiGene Announces Preliminary Phase 2 Results of Tislelizumab for Naso...

6/14/2019Beigene Touts 'Encouraging' Response Rates as It Mounts Challenge To B...

6/14/2019NMPA Restores Import of Fabrik Evers' HITRECHOL

6/13/2019AstraZeneca Markets an Herbal-Based Remedy to Expand in China

6/13/2019SEC probes Siemens, GE, Philips in alleged China medical equipment sch...

6/13/2019Athenex and PharmaEssentia Announce Positive Early Clinical Signals of...

6/13/2019Chinese Biopharma Firm Epimab Bags $74m Series B

6/13/2019Parexel Teams with CLARINESS to Enhance Patient Access and Engagement ...

6/13/2019US Senators Questions HHS Money and Chinese Genomics Firms

6/13/2019The U.S. Is Purging Chinese Cancer Researchers From Top Institutions

6/13/2019Analyst Predicts Delay in Medytox's Obtaining Beijing's Nod for Botuli...

6/13/2019Terns Pharma Initiates a Phase 1 Clinical Trial of TERN-101

6/13/2019In Depth: Why China's Drug-Review Revamp Is Stalling

6/13/2019IBT: China Can Weaponize Prescription Drugs to Hit US in Trade War, Sa...

6/13/2019China's Churning Out Revolutionary Cancer Drugs Much Cheaper Than the ...

6/12/2019China Issues Notice on Promoting Healthy Development of Social Capital...

6/12/2019Health Care Data Compliance in China: FAQ

6/11/2019Exscientia and GT Apeiron Enter A Multi-target AI Drug Discovery Partn...

6/10/2019China to Set Up More Medical Alliances in Cities and Counties

6/10/2019China Issues New Regulation to Tighten Use of Genetic Material by Fore...

6/10/2019Recent Executive Moves

6/10/2019CStone and Bayer Agree to Evaluate PD-L1 mAb CS1001 and Regorafenib Co...

6/6/2019BioMarin's Vimizim Approved in China for Rare Genetic Malady

6/6/2019Achaogen Disposes Most Assets to Cipla and Qilu thru Auction

Page:142/361 Total number of articles:10802: [First][<<] [140] [141] [142] [143] [144] [>>] [End]